INTERNATIONAL JOURNAL OF LATEST TECHNOLOGY IN ENGINEERING,
MANAGEMENT & APPLIED SCIENCE (IJLTEMAS)
ISSN 2278-2540 | DOI: 10.51583/IJLTEMAS | Volume XIII, Issue XII, December 2024
www.ijltemas.in Page 212
Nanoparticles possess unique properties due to their small size, which can influence their interactions with biological systems.
AuNPs, with their precisely controlled sizes, exhibit high surface area-to-volume ratios, enhancing their interactions with bacteria
(30). Moreover, their antibacterial mechanisms, including membrane disruption and reactive oxygen species (ROS) generation,
contribute to their effectiveness against a broad spectrum of bacteria.while gram-negative bacteria typically present greater
resistance due to their outer membrane, AuNPs demonstrate efficacy against both gram-negative and gram-positive bacteria.
However, there's a noted variation in susceptibility, as evidenced by the smaller inhibition zones observed for gram-positive
bacteria such as S. aureus and B. subtilis.
Surface functionalization of nanoparticles can further enhance their antibacterial activity by modulating their interactions with
bacteria. This includes attaching molecules to the nanoparticle surface to improve stability, biocompatibility, and targeting
specificity.
Characterization techniques such as transmission electron microscopy (TEM) and dynamic light scattering (DLS) provide crucial
insights into nanoparticle properties, such as size, morphology, and stability. These analyses help understand nanoparticle
behavior and optimize their design for antibacterial applications.
While the results show promise, challenges remain in the clinical translation of nanoparticle- based therapies. Issues related to
scalability, regulatory approval, and cost-effectiveness need to be addressed for widespread clinical use. Nevertheless, ongoing
research efforts aim to overcome these hurdles and advance nanoparticle-based antibacterial therapies toward clinical
applications.
IV. Conclusion
Visual inspection and characterization indicate successful synthesis of gold nanoparticle from Croton megalocarpus leaves
extracts. The stirring time is short and convenient for fast mass production. The produced nanoparticles had longer shelf life
without requirement of special storage conditions. The nanoparticle produced did not show any agglomeration and the size of
26nm and the morphology provide a wide range biological applications. The Nanoparticles characteristically had good
antimicrobial properties and combining nanoparticle with drug resulted into synergistic effects. Therefore it can be concluded that
croton megalocarpus leaves extract is suitable for the production of gold nanoparticles. It provide, efficient, easy, less costly and
environmental friendly way of synthesis. This research therefore achieved its objectives and the the knowledge will contribute to
the body of science with the hope that the nanoparticles produced will have great impact in solving antimicrobial resistance.
Conflicts of Interest
There is no conflict of interest by any party involved in this study. This journal is an original work that has not been published or
in process of being published in any by any other publisher. On behalf of all Co-Authors, the Author shall bear full responsibility
for the submission.
References
1. Čiginskienė, A. et al. (2019) “Ventilator-associated pneumonia due to drug-resistant Acinetobacter baumannii: Risk
factors and mortality relation with resistance profiles, and independent predictors of in-hospital mortality,” Medicina,
55(2), p. 49. Available at: https://doi.org/10.3390/medicina55020049
2. Silva, Ana C., et al. “Determinants of Antimicrobial Resistance among the Different European Countries: More than
Human and Animal Antimicrobial Consumption.” Antibiotics, vol. 10, no. 7, 2021, p. 834.,
https://doi.org/10.3390/antibiotics10070834.
3. “The future of antibiotics – has resistance switched out the light at the end of the tunnel?” (2001) Magic Bullets, Lost
Horizons, pp. 243–264. Available at: https://doi.org/10.1201/b12641-11.
4. Ayukekbong, J., Ntemgwa, M., &Atabe, A. (2017). The threat of antimicrobial resistance in developing countries:
causes and control strategies. Antimicrobial Resistance & Infection Control, 6(1). doi: 10.1186/s13756-017-0208
5. Heifets, Leonid, and Gerard Cangelosi. “Drug Resistance Assays for Mycobacterium Tuberculosis.” Antimicrobial Drug
Resistance, 2009, pp. 1161–1170., https://doi.org/10.1007/978-1-60327-595-8_35.
6. Michael, C., Dominey-Howes, D., &Labbate, M. (2014). The Antimicrobial Resistance Crisis: Causes, Consequences,
and Management. Frontiers In Public Health, 2. doi: 10.3389/fpubh.2014.00145
7. Mohammadi, B. and Salouti, M. (2014) “Extracellular bioynthesis of silver nanoparticles by penicillium chrysogenum
and penicillium expansum,” Synthesis and Reactivity in Inorganic, Metal-Organic, and Nano-Metal Chemistry, 45(6),
pp. 844–847. Available at: https://doi.org/10.1080/15533174.2013.862640.
8. Drug resistance updates meetings-courses-workshops” (2003) Drug Resistance Updates, 6(4), pp. 225–230. Available at:
https://doi.org/10.1016/s1368-7646(03)00066-9.
9. De Jong, W. H., &Borm, P. J. (2008). Drug delivery and nanoparticles: Applications and hazards. International Journal
of Nanomedicine, 3(2), 133–149.
10. Munir, M.M., Ogi, T. and Okuyama, K. (2018) “Nanoparticle synthesis, dispersion, and functionalization for Industrial
Application,” Nanoparticle Technology Handbook, pp. 675–681. Available at: https://doi.org/10.1016/b978-0-444-
64110-6.00059-7.